Capricor Therapeutics Inc (CAPR) is a publicly traded Healthcare sector company. As of November 3, 2026, CAPR trades at $7.38 with a market cap of $370.93M and a P/E ratio of -7.84. CAPR moved +0.69% today. Year to date, CAPR is -74.94%; over the trailing twelve months it is +16.46%. Its 52-week range spans $2.96 to $40.37. Analyst consensus is buy with an average price target of $27.00. Rallies surfaces CAPR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for CAPR, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $7.38 |
| Market Cap | $370.93M |
| P/E Ratio | -7.84 |
| EPS | $-1.15 |
| Dividend Yield | 0.00% |
| 52-Week High | $40.37 |
| 52-Week Low | $2.96 |
| Volume | 875.53K |
| Avg Volume | 0 |
| Revenue (TTM) | $22.27M |
| Net Income | $-40.47M |
| Gross Margin | 0.00% |
8 analysts cover CAPR: 0 strong buy, 4 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $27.00.